A Case Report of Posttransplant Lymphoproliferative Disorder After AstraZeneca Coronavirus Disease 2019 Vaccine in a Heart Transplant Recipient

Wen Ruei Tang, Che Wei Hsu, Chia Chi Lee, Wei Li Huang, Chia Ying Lin, Ya Ting Hsu, Chen Chang, Meng Ta Tsai, Yu Ning Hu, Chih Hsin Hsu, Po Lin Chen, Nan Haw Chow, Jun Neng Roan

研究成果: Article同行評審

8 引文 斯高帕斯(Scopus)

摘要

We report a case of a heart transplant recipient who presented with a rapidly growing Epstein-Barr virus (EBV)–positive, diffuse large B-cell lymphoma 7 days after receiving the first dose of the ChAdOx1 nCoV-19 vaccine. Because of the atypical radiologic presentation, the initial tentative diagnosis was a mediastinal abscess. This observation indicates a potential risk of EBV reactivation after coronavirus disease 2019 (COVID-19) vaccination, which might lead to or aggravate the presentation of posttransplant lymphoproliferative disorder in transplantation patients. Transplant surgeons should be aware of the potential immunomodulatory effects of the COVID-19 vaccination.

原文English
頁(從 - 到)1575-1578
頁數4
期刊Transplantation Proceedings
54
發行號6
DOIs
出版狀態Published - 2022 7月 1

All Science Journal Classification (ASJC) codes

  • 手術
  • 移植

指紋

深入研究「A Case Report of Posttransplant Lymphoproliferative Disorder After AstraZeneca Coronavirus Disease 2019 Vaccine in a Heart Transplant Recipient」主題。共同形成了獨特的指紋。

引用此